Circulating BRAF(V600E) Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Background: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC) and can be associated with aggressive disease. Previously, a highly sensitive blood RNA-based BRAF(V600E) assay was reported. The objective of this study was to assess the correlation of BRAF(V600E) circulating...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Thyroid
मुख्य लेखकों: Lubitz, Carrie C., Zhan, Tiannan, Gunda, Viswanath, Amin, Salma, Gigliotti, Benjamin J., Fingeret, Abbey L., Holm, Tammy M., Wachtel, Heather, Sadow, Peter M., Wirth, Lori J., Sullivan, Ryan J., Panka, David J., Parangi, Sareh
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Mary Ann Liebert, Inc. 2018
विषय:
Thyroid Cancer and Nodules
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865613/
https://ncbi.nlm.nih.gov/pubmed/29378474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0322
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन